$17BN
AUM
Messenger RNA targeting to create life-saving therapeutics
ADARx is developing a proprietary RNA targeting platform, including oligonucleotides for inhibition, degradation, and editing, together with novel oligonucleotide delivery technologies.
People with cancer can’t wait. Let’s go.
SpringWorks applies a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer.
Pushing targeted oncology drug discovery to new heights
Treeline Biosciences is pursuing molecular targets in oncology that are validated but difficult to drug, leveraging its four pillars of drug discovery: mechanistic biology, medicinal chemistry, computational science, and structural biology and protein science.
Developing next-generation kinase inhibitors
Theseus is a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies.
Missing Link in Telehealth
TytoCare is transforming primary care by putting health in the hands of consumers.
Providing tailored financing solutions and global team resources to help build world-class healthcare companies.
From biopharmaceuticals to medical devices, digital health, diagnostics, and healthcare services, OrbiMed is scouting the globe for innovations that will help ensure humanity lives healthier, longer, and more productive lives.
We have been investing globally for over 20 years across the healthcare industry: from early-stage private companies to large multinational corporations. Our team of over 100 distinguished scientific, medical, investment, and other professionals manages over $17 billion across public and private company investments worldwide.
500+
Portfolio Companies
100+
Total Professionals
OrbiMed News
Portfolio Company News
Exciting healthcare breakthroughs are occurring worldwide, so our team is working diligently around the globe to find them.
For general inquiries please contact us at +1 (212) 739-6400.
New York
601 Lexington Avenue(at 53rd Street), 54th Floor
New York, NY 10022-4629
+1 (212) 739-6400
London
22a St. James’s SquareLondon
SW1Y 4JH
Shanghai
Unit 4706, Raffles City, Shanghai Office Tower268 Xizang Middle Road
Shanghai 200001, P.R. China
+ (86) 21-6335-1700
Hong Kong
The Executive Centre Hong Kong LimitedNexxus Building, Suite 1536
41 Connaught Road Central
Central, Hong Kong, China